The effect of inflammation, SARS-CoV-2 infection, age and mental health on serotonin, and kynurenine and catecholamine pathway metabolites

[1]  Guohui Fan,et al.  6-month consequences of COVID-19 in patients discharged from hospital: a cohort study , 2023, The Lancet.

[2]  K. Kurz,et al.  COVID-19 and its continuing burden after 12 months: a longitudinal observational prospective multicentre trial , 2023, ERJ Open Research.

[3]  I. Kolassa,et al.  Inflammation and severity of depressive symptoms in physically active individuals after COVID-19 – An exploratory immunopsychological study investigating the effect of inflammation on depressive symptom severity , 2023, Brain, Behavior, & Immunity - Health.

[4]  F. Bösch,et al.  Kynurenine serves as useful biomarker in acute, Long- and Post-COVID-19 diagnostics , 2022, Frontiers in Immunology.

[5]  S. Ivković,et al.  Tryptophan metabolites in depression: Modulation by gut microbiota , 2022, Frontiers in Behavioral Neuroscience.

[6]  J. Moncrieff,et al.  The serotonin theory of depression: a systematic umbrella review of the evidence , 2022, Molecular Psychiatry.

[7]  M. Manchia,et al.  Indoleamine 2,3-dioxygenase (IDO)-activity in severe psychiatric disorders: A systemic review. , 2022, Current topics in medicinal chemistry.

[8]  S. Candansayar,et al.  Psychological outcomes of COVID-19 survivors at sixth months after diagnose: the role of kynurenine pathway metabolites in depression, anxiety, and stress , 2022, Journal of Neural Transmission.

[9]  C. Barbas,et al.  Metabolic Profiling at COVID-19 Onset Shows Disease Severity and Sex-Specific Dysregulation , 2022, Frontiers in Immunology.

[10]  L. Brundin,et al.  Increased levels of circulating neurotoxic metabolites in patients with mild Covid19 , 2022, bioRxiv.

[11]  N. Mechawar,et al.  Microglial Inflammatory-Metabolic Pathways and Their Potential Therapeutic Implication in Major Depressive Disorder , 2022, Frontiers in Psychiatry.

[12]  M. Jadoul,et al.  Urine metabolomics links dysregulation of the tryptophan-kynurenine pathway to inflammation and severity of COVID-19 , 2022, Scientific Reports.

[13]  B. Brew,et al.  Post-acute COVID-19 cognitive impairment and decline uniquely associate with kynurenine pathway activation: a longitudinal observational study , 2022, medRxiv.

[14]  X. Wang,et al.  Sustained abnormality with recovery of COVID-19 convalescents: a 2-year follow-up study , 2022, Science bulletin.

[15]  J. Bower,et al.  Psychoneuroimmunology in the time of COVID-19: Why neuro-immune interactions matter for mental and physical health , 2022, Behaviour Research and Therapy.

[16]  K. Kurz,et al.  Who Is at Risk of Poor Mental Health Following Coronavirus Disease-19 Outpatient Management? , 2022, Frontiers in Medicine.

[17]  Michael Maes,et al.  The tryptophan catabolite or kynurenine pathway in COVID-19 and critical COVID-19: a systematic review and meta-analysis , 2022, BMC Infectious Diseases.

[18]  Inyoul Y. Lee,et al.  Multiple early factors anticipate post-acute COVID-19 sequelae , 2022, Cell.

[19]  M. Solmi,et al.  The tryptophan catabolite or kynurenine pathway in schizophrenia: meta-analysis reveals dissociations between central, serum, and plasma compartments , 2021, Molecular Psychiatry.

[20]  M. Reindl,et al.  12-month SARS-CoV-2 antibody persistency in a Tyrolean COVID-19 cohort , 2021, Wiener klinische Wochenschrift.

[21]  M. Cominetti,et al.  Phenylalanine and COVID-19: Tracking disease severity markers , 2021, International Immunopharmacology.

[22]  T. Hinterberger,et al.  Associations of Post-Acute COVID syndrome with physiological and clinical measures 10 months after hospitalization in patients of the first wave , 2021, European Journal of Internal Medicine.

[23]  J. Gostner,et al.  Neurotransmitter Precursor Amino Acid Ratios Show Differential, Inverse Correlations with Depression Severity in the Low and High Depression Score Range , 2021, International journal of tryptophan research : IJTR.

[24]  K. Newell,et al.  The kynurenine pathway in major depression: What we know and where to next , 2021, Neuroscience & Biobehavioral Reviews.

[25]  G. S. Güven,et al.  Altered tryptophan absorption and metabolism could underlie long-term symptoms in survivors of coronavirus disease 2019 (COVID-19) , 2021, Nutrition.

[26]  Benjamin Bowe,et al.  High-dimensional characterization of post-acute sequelae of COVID-19 , 2021, Nature.

[27]  Guohui Fan,et al.  RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study , 2021, The Lancet.

[28]  F. Nicoletti,et al.  Increased kynurenine-to-tryptophan ratio in the serum of patients infected with SARS-CoV2: An observational cohort study. , 2020, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease.

[29]  A. Carvalho,et al.  The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a meta-analysis of 101 studies , 2020, Molecular Psychiatry.

[30]  Mark M. Davis,et al.  Multi-Omics Resolves a Sharp Disease-State Shift between Mild and Moderate COVID-19 , 2020, Cell.

[31]  Constanza de Dios,et al.  Effect of immune activation on the kynurenine pathway and depression symptoms – A systematic review and meta-analysis , 2020, Neuroscience & Biobehavioral Reviews.

[32]  W. Freidl,et al.  Frailty and depression: Reciprocal influences or common causes? , 2020, Social science & medicine.

[33]  E. Hod,et al.  COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status. , 2020, JCI insight.

[34]  S. Yusuf,et al.  Association of Symptoms of Depression With Cardiovascular Disease and Mortality in Low-, Middle-, and High-Income Countries. , 2020, JAMA psychiatry.

[35]  J. Gostner,et al.  Acute and Chronic Mental Stress both Influence Levels of Neurotransmitter Precursor Amino Acids and Derived Biogenic Amines , 2020, Brain sciences.

[36]  J. Gostner,et al.  The significance of tryptophan metabolism and vitamin B-6 status in cardiovascular disease. , 2019, The American journal of clinical nutrition.

[37]  P. Naudé,et al.  Tryptophan Metabolism in Inflammaging: From Biomarker to Therapeutic Target , 2019, Front. Immunol..

[38]  D. Fuchs,et al.  How acute and chronic physical disease may influence mental health – An Analysis of neurotransmitter precursor amino acid levels , 2019, Psychoneuroendocrinology.

[39]  J. Gostner,et al.  Immunological alterations in frail older adults: A cross sectional study , 2018, Experimental Gerontology.

[40]  N. Castanon,et al.  Brain Kynurenine and BH4 Pathways: Relevance to the Pathophysiology and Treatment of Inflammation-Driven Depressive Symptoms , 2018, Front. Neurosci..

[41]  J. Ruas,et al.  Kynurenines: Tryptophan’s metabolites in exercise, inflammation, and mental health , 2017, Science.

[42]  Yong-Ku Kim,et al.  The influence of stress on neuroinflammation and alterations in brain structure and function in major depressive disorder , 2017, Behavioural Brain Research.

[43]  A. Badawy.  Kynurenine Pathway of Tryptophan Metabolism: Regulatory and Functional Aspects , 2017, International journal of tryptophan research : IJTR.

[44]  J. Kleinman,et al.  Reduced kynurenine pathway metabolism and cytokine expression in the prefrontal cortex of depressed individuals. , 2016, Journal of psychiatry & neuroscience : JPN.

[45]  D. Fuchs,et al.  Levels in neurotransmitter precursor amino acids correlate with mental health in patients with breast cancer , 2015, Psychoneuroendocrinology.

[46]  M. Finel,et al.  Determination of Serotonin and Dopamine Metabolites in Human Brain Microdialysis and Cerebrospinal Fluid Samples by UPLC-MS/MS: Discovery of Intact Glucuronide and Sulfate Conjugates , 2013, PloS one.

[47]  J. Gostner,et al.  Immune activation and inflammation increase the plasma phenylalanine-to-tyrosine ratio , 2013 .

[48]  Daniel Weindl,et al.  Complexity of dopamine metabolism , 2013, Cell Communication and Signaling.

[49]  M. Maes,et al.  Depression and sickness behavior are Janus-faced responses to shared inflammatory pathways , 2012, BMC Medicine.

[50]  R. Schwarcz,et al.  Kynurenines in the mammalian brain: when physiology meets pathology , 2012, Nature Reviews Neuroscience.

[51]  P. Barberger‐Gateau,et al.  Chronic Low-Grade Inflammation in Elderly Persons Is Associated with Altered Tryptophan and Tyrosine Metabolism: Role in Neuropsychiatric Symptoms , 2011, Biological Psychiatry.

[52]  N. Meader,et al.  Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies. , 2011, The Lancet. Oncology.

[53]  D. Fuchs,et al.  Chronic immune stimulation correlates with reduced phenylalanine turnover. , 2008, Current drug metabolism.

[54]  S. Weis,et al.  Alterations in kynurenine precursor and product levels in schizophrenia and bipolar disorder , 2008, Neurochemistry International.

[55]  R. Peters,et al.  Ageing and the brain , 2006, Postgraduate Medical Journal.

[56]  R. Snaith,et al.  The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.

[57]  K. Shirey,et al.  Synergistic Transcriptional Activation of Indoleamine Dioxygenase by IFN-γ and Tumor Necrosis Factor-α , 2003 .

[58]  T. T. Haug,et al.  The validity of the Hospital Anxiety and Depression Scale. An updated literature review. , 2002, Journal of psychosomatic research.

[59]  H. Meltzer,et al.  Increased Depressive Ratings in Patients With Hepatitis C Receiving Interferon-α–Based Immunotherapy Are Related to Interferon-α–Induced Changes in the Serotonergic System , 2002 .

[60]  C. Dickens,et al.  The burden of depression in patients with rheumatoid arthritis. , 2001, Rheumatology.

[61]  D. Goldstein,et al.  Sources and physiological significance of plasma dopamine sulfate. , 1999, The Journal of clinical endocrinology and metabolism.

[62]  R. P. McDonald,et al.  Test Theory: A Unified Treatment , 1999 .

[63]  E. Werner,et al.  Simultaneous measurement of serum tryptophan and kynurenine by HPLC. , 1997, Clinical chemistry.

[64]  P. Blockx,et al.  The effects of glucocorticoids on the availability of L-tryptophan and tyrosine in the plasma of depressed patients. , 1990, Journal of affective disorders.

[65]  J. Hoofnagle,et al.  Psychiatric complications of long-term interferon alfa therapy. , 1987, Archives of internal medicine.

[66]  T. Kamarck,et al.  A global measure of perceived stress. , 1983, Journal of health and social behavior.

[67]  R. Dantzer,et al.  From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.

[68]  Gábor Csárdi,et al.  The igraph software package for complex network research , 2006 .

[69]  B. Ripley,et al.  Robust Statistics , 2018, Encyclopedia of Mathematical Geosciences.

[70]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[71]  P. Swanson,et al.  The effects of the , 1975 .

[72]  W. Knox.  Two mechanisms which increase in vivo the liver tryptophan peroxidase activity: specific enzyme adaptation and stimulation of the pituitary adrenal system. , 1951, British journal of experimental pathology.